COMEXPOSIUM HEALTHCARE : revenue, balance sheet and financial ratios

COMEXPOSIUM HEALTHCARE is a French company founded 31 years ago, specialized in the sector Organisation de foires, salons professionnels et congrès. Based in PARIS (75008), this company of category GE shows in 2020 a revenue of 13.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - COMEXPOSIUM HEALTHCARE (SIREN 398340356)
Indicator 2020 2019 2018 2017 2016
Revenue 13 658 705 € 9 834 960 € 8 638 451 € 6 631 594 € 5 160 872 €
Net income 4 646 986 € 2 511 489 € 1 843 227 € 1 055 226 € 672 111 €
EBITDA 6 673 352 € 3 788 523 € 2 842 668 € 1 763 567 € 946 556 €
Net margin 34.0% 25.5% 21.3% 15.9% 13.0%

Revenue and income statement

In 2020, COMEXPOSIUM HEALTHCARE achieves revenue of 13.7 M€. Over the period 2016-2020, the company shows strong growth with a CAGR (compound annual growth rate) of +27.5%. Vs 2019, growth of +39% (9.8 M€ -> 13.7 M€). After deducting consumption (0 €), gross margin stands at 13.7 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 6.7 M€, representing 48.9% of revenue. Positive scissor effect: EBITDA margin improves by +10.3 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 4.6 M€, i.e. 34.0% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2020) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

13 658 705 €

Gross margin (2020) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

13 658 705 €

EBITDA (2020) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

6 673 352 €

EBIT (2020) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

6 539 994 €

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

4 646 986 €

EBITDA margin (2020) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

48.8%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 21%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 74%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.2 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 35.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

20.595%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

73.866%

Cash flow / Revenue (2020) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

35.374%

Repayment capacity (2020) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.2

Asset age ratio (2020) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

41.7%

Solvency indicators evolution
COMEXPOSIUM HEALTHCARE

Sector positioning

Debt ratio
20.59 2020
2018
2019
2020
Q1: 0.0
Med: 4.22
Q3: 92.05
Average

In 2020, the debt ratio of COMEXPOSIUM HEALTHCARE (20.59) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
73.87% 2020
2018
2019
2020
Q1: 0.12%
Med: 23.9%
Q3: 55.17%
Excellent +24 pts over 3 years

In 2020, the financial autonomy of COMEXPOSIUM HEALTHCARE (73.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.2 years 2020
2018
2019
2020
Q1: -0.7 years
Med: 0.0 years
Q3: 0.25 years
Average +13 pts over 3 years

In 2020, the repayment capacity of COMEXPOSIUM HEALTHCARE (0.20) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1598.45. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.8x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2020) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1598.446

Interest coverage (2020) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.769

Liquidity indicators evolution
COMEXPOSIUM HEALTHCARE

Sector positioning

Liquidity ratio
1598.45 2020
2018
2019
2020
Q1: 113.62
Med: 203.5
Q3: 408.19
Excellent

In 2020, the liquidity ratio of COMEXPOSIUM HEALTHCARE (1598.45) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.77x 2020
2018
2019
2020
Q1: -0.13x
Med: 0.0x
Q3: 0.0x
Excellent +15 pts over 3 years

In 2020, the interest coverage of COMEXPOSIUM HEALTHCARE (0.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 2 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 4 days. Favorable situation: supplier credit is longer than customer credit by 2 days. Overall, WCR represents 69 days of revenue, i.e. 2.6 M€ to permanently finance. Over 2016-2020, WCR increased by +170%, requiring additional financing.

Operating WCR (2020) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

2 620 832 €

Customer credit (2020) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

2 j

Supplier credit (2020) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

4 j

Inventory turnover (2020) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2020) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

69 j

WCR and payment terms evolution
COMEXPOSIUM HEALTHCARE

Positioning of COMEXPOSIUM HEALTHCARE in its sector

Comparison with sector Organisation de foires, salons professionnels et congrès

Valuation estimate

Based on 63 transactions of similar company sales (all years), the value of COMEXPOSIUM HEALTHCARE is estimated at 9 645 820 € (range 4 580 850€ - 31 471 475€). With an EBITDA of 6 673 352€, the sector multiple of 1.6x is applied. The price/revenue ratio is 0.68x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2020
63 tx
4580k€ 9645k€ 31471k€
9 645 820 € Range: 4 580 850€ - 31 471 475€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
6 673 352 € × 1.6x
Estimation 10 424 134 €
4 946 043€ - 41 259 452€
Revenue Multiple 30%
13 658 705 € × 0.68x
Estimation 9 293 318 €
3 542 436€ - 17 277 327€
Net Income Multiple 20%
4 646 986 € × 1.8x
Estimation 8 228 792 €
5 225 494€ - 28 292 758€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 63 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Organisation de foires, salons professionnels et congrès)

Compare COMEXPOSIUM HEALTHCARE with other companies in the same sector:

Voir toutes les statistiques du secteur Organisation de foires, salons professionnels et congrès

Frequently asked questions about COMEXPOSIUM HEALTHCARE

What is the revenue of COMEXPOSIUM HEALTHCARE ?

The revenue of COMEXPOSIUM HEALTHCARE in 2020 is 13.7 M€.

Is COMEXPOSIUM HEALTHCARE profitable?

Yes, COMEXPOSIUM HEALTHCARE generated a net profit of 4.6 M€ in 2020.

Where is the headquarters of COMEXPOSIUM HEALTHCARE ?

The headquarters of COMEXPOSIUM HEALTHCARE is located in PARIS (75008), in the department Paris.

Where to find the tax return of COMEXPOSIUM HEALTHCARE ?

The tax return of COMEXPOSIUM HEALTHCARE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does COMEXPOSIUM HEALTHCARE operate?

COMEXPOSIUM HEALTHCARE operates in the sector Organisation de foires, salons professionnels et congrès (NAF code 82.30Z). See the 'Sector positioning' section above to compare the company with its competitors.